Valuation : Abnova (Taiwan) Corporation.

Market Cap 1.24B 39.33M 33.84M 31.84M 29.09M 54.42M 3.71B 54.56M 376M 146M 1.91B 148M 144M 6.14B P/E 2024
29.1x
P/E 2025 -1,135x
Enterprise Value 885M 27.97M 24.07M 22.65M 20.69M 38.7M 2.64B 38.81M 268M 104M 1.36B 105M 103M 4.37B EV / Sales 2024
3.86x
EV / Sales 2025 2.89x
Free-Float
76.89%
Yield 2024
3.04%
Yield 2025 0.49%
Manager TitleAgeSince
Chief Executive Officer - -
Investor Relations Contact - -
Comptroller/Controller/Auditor - -
Director TitleAgeSince
Director/Board Member 62 2020-06-18
Chairman 60 -
Director/Board Member 75 2017-06-22
Change 5-day change 1-year change 3-year change Capi.($)
-1.79%-2.27%+43.23%+88.96% 67.98B
-2.06%-0.18%+39.67%+86.44% 64.94B
-0.31%+6.54%-12.96%+378.92% 27.58B
+0.86%+1.65%-7.74%-14.95% 26.06B
-3.00%-2.90%+33.13%+12.54% 25.74B
-1.46%+0.42%+23.61%-18.61% 20.09B
-2.96%-15.21%+216.20%+368.10% 17.16B
-1.49%-4.88%-6.60%+531.89% 14.92B
-0.20%+8.37%+55.78%+164.98% 14.62B
Average -1.38%+0.26%+42.70%+177.58% 31.01B
Weighted average by Cap. -1.52%+0.18%+38.37%+137.35%

Financials

2024 2025
Net sales 355M 11.23M 9.66M 9.09M 8.3M 15.54M 1.06B 15.58M 107M 41.69M 544M 42.17M 41.25M 1.75B 351M 11.1M 9.55M 8.99M 8.21M 15.36M 1.05B 15.4M 106M 41.22M 538M 41.7M 40.79M 1.73B
Net income 61.61M 1.95M 1.68M 1.58M 1.44M 2.69M 184M 2.7M 18.63M 7.23M 94.33M 7.31M 7.15M 304M -1.14M -36.06K -31.03K -29.2K -26.67K -49.9K -3.41M -50.03K -345K -134K -1.75M -135K -132K -5.63M
Net Debt -424M -13.41M -11.54M -10.85M -9.91M -18.55M -1.27B -18.6M -128M -49.77M -649M -50.34M -49.24M -2.09B -359M -11.36M -9.77M -9.2M -8.4M -15.71M -1.07B -15.76M -109M -42.16M -550M -42.65M -41.72M -1.77B
Logo Abnova (Taiwan) Corporation.
Abnova Taiwan Corp is a Taiwan-based company principally engaged in the manufacturing and sales of antibodies and proteins. The Company's products mainly include monoclonal antibodies, polyclonal antibodies, protein fragments, full-length proteins, active proteins, antibody pairs, fluorescence in situ hybridization probe and others. The Company's monoclonal and polyclonal antibodies are primarily applied in medical testing reagents, agricultural testing, industrial purification, medical treatment and other fields. Its proteins are mainly applied in medical testing reagents, agricultural testing, medical treatment, protein engineering and other fields. Its products are mainly traded in Taiwan, Americas and Europe.
Employees
-